vs

Side-by-side financial comparison of Hyperfine, Inc. (HYPR) and Marygold Companies, Inc. (MGLD). Click either name above to swap in a different company.

Marygold Companies, Inc. is the larger business by last-quarter revenue ($7.6M vs $5.3M, roughly 1.4× Hyperfine, Inc.). Marygold Companies, Inc. runs the higher net margin — -7.5% vs -111.7%, a 104.2% gap on every dollar of revenue. On growth, Hyperfine, Inc. posted the faster year-over-year revenue change (128.0% vs -4.5%). Over the past eight quarters, Hyperfine, Inc.'s revenue compounded faster (26.7% CAGR vs -1.5%).

Hyperfine, Inc. develops and commercializes innovative portable low-field magnetic resonance imaging (MRI) systems for medical diagnostic use. Its solutions deliver accessible, cost-effective imaging for healthcare providers across acute care, rural clinics, pediatric care, and other underserved clinical settings worldwide.

Marygold Companies, Inc. is a U.S.-headquartered diversified holding company that operates across three core segments: financial services, specialty manufacturing, and consumer goods. It primarily caters to North American markets, driving long-term value growth via strategic investment in, and operational optimization of, its portfolio of subsidiary entities.

HYPR vs MGLD — Head-to-Head

Bigger by revenue
MGLD
MGLD
1.4× larger
MGLD
$7.6M
$5.3M
HYPR
Growing faster (revenue YoY)
HYPR
HYPR
+132.6% gap
HYPR
128.0%
-4.5%
MGLD
Higher net margin
MGLD
MGLD
104.2% more per $
MGLD
-7.5%
-111.7%
HYPR
Faster 2-yr revenue CAGR
HYPR
HYPR
Annualised
HYPR
26.7%
-1.5%
MGLD

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
HYPR
HYPR
MGLD
MGLD
Revenue
$5.3M
$7.6M
Net Profit
$-5.9M
$-576.0K
Gross Margin
50.9%
74.0%
Operating Margin
-144.9%
-8.3%
Net Margin
-111.7%
-7.5%
Revenue YoY
128.0%
-4.5%
Net Profit YoY
43.1%
67.0%
EPS (diluted)
$-0.05
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HYPR
HYPR
MGLD
MGLD
Q4 25
$5.3M
$7.6M
Q3 25
$3.4M
$7.0M
Q2 25
$2.7M
$7.2M
Q1 25
$2.1M
$7.0M
Q4 24
$2.3M
$8.0M
Q3 24
$3.6M
$7.9M
Q2 24
$3.6M
$8.3M
Q1 24
$3.3M
$7.9M
Net Profit
HYPR
HYPR
MGLD
MGLD
Q4 25
$-5.9M
$-576.0K
Q3 25
$-11.0M
$-356.0K
Q2 25
$-9.2M
$-1.5M
Q1 25
$-9.4M
$-1.0M
Q4 24
$-10.4M
$-1.7M
Q3 24
$-10.3M
$-1.6M
Q2 24
$-10.2M
$-1.9M
Q1 24
$-9.8M
$-529.0K
Gross Margin
HYPR
HYPR
MGLD
MGLD
Q4 25
50.9%
74.0%
Q3 25
53.8%
77.0%
Q2 25
49.3%
67.8%
Q1 25
41.3%
75.0%
Q4 24
35.6%
74.1%
Q3 24
52.4%
73.1%
Q2 24
49.7%
72.5%
Q1 24
41.1%
70.5%
Operating Margin
HYPR
HYPR
MGLD
MGLD
Q4 25
-144.9%
-8.3%
Q3 25
-259.5%
-18.2%
Q2 25
-355.9%
-16.5%
Q1 25
-510.2%
-21.4%
Q4 24
-463.8%
-22.8%
Q3 24
-300.9%
-27.4%
Q2 24
-298.7%
-33.3%
Q1 24
-323.2%
-18.7%
Net Margin
HYPR
HYPR
MGLD
MGLD
Q4 25
-111.7%
-7.5%
Q3 25
-320.6%
-5.1%
Q2 25
-342.2%
-20.4%
Q1 25
-440.7%
-14.4%
Q4 24
-447.7%
-21.8%
Q3 24
-283.4%
-20.1%
Q2 24
-279.7%
-22.5%
Q1 24
-298.9%
-6.7%
EPS (diluted)
HYPR
HYPR
MGLD
MGLD
Q4 25
$-0.05
$-0.01
Q3 25
$-0.14
$-0.01
Q2 25
$-0.12
$-0.04
Q1 25
$-0.12
$-0.02
Q4 24
$-0.14
$-0.04
Q3 24
$-0.14
$-0.04
Q2 24
$-0.14
$-0.05
Q1 24
$-0.14
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HYPR
HYPR
MGLD
MGLD
Cash + ST InvestmentsLiquidity on hand
$35.1M
$11.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.0M
$22.7M
Total Assets
$55.3M
$27.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HYPR
HYPR
MGLD
MGLD
Q4 25
$35.1M
$11.6M
Q3 25
$21.6M
$12.5M
Q2 25
$25.4M
$12.8M
Q1 25
$33.1M
$15.6M
Q4 24
$37.6M
$14.9M
Q3 24
$45.8M
$17.5M
Q2 24
$53.8M
$15.0M
Q1 24
$63.2M
$16.1M
Stockholders' Equity
HYPR
HYPR
MGLD
MGLD
Q4 25
$41.0M
$22.7M
Q3 25
$26.9M
$22.9M
Q2 25
$35.1M
$23.0M
Q1 25
$43.1M
$24.3M
Q4 24
$49.0M
$23.4M
Q3 24
$58.3M
$25.5M
Q2 24
$66.8M
$26.6M
Q1 24
$75.6M
$28.4M
Total Assets
HYPR
HYPR
MGLD
MGLD
Q4 25
$55.3M
$27.8M
Q3 25
$41.5M
$28.4M
Q2 25
$45.2M
$30.4M
Q1 25
$53.4M
$33.5M
Q4 24
$58.9M
$33.0M
Q3 24
$69.4M
$35.9M
Q2 24
$76.6M
$32.9M
Q1 24
$85.4M
$33.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HYPR
HYPR
MGLD
MGLD
Operating Cash FlowLast quarter
$-5.2M
$-908.0K
Free Cash FlowOCF − Capex
$-5.3M
FCF MarginFCF / Revenue
-99.6%
Capex IntensityCapex / Revenue
1.2%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-29.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HYPR
HYPR
MGLD
MGLD
Q4 25
$-5.2M
$-908.0K
Q3 25
$-5.6M
$-533.0K
Q2 25
$-7.9M
$-3.3M
Q1 25
$-9.2M
$-1.2M
Q4 24
$-8.4M
$-770.0K
Q3 24
$-8.5M
$-893.0K
Q2 24
$-9.4M
$-1.9M
Q1 24
$-12.5M
$-658.0K
Free Cash Flow
HYPR
HYPR
MGLD
MGLD
Q4 25
$-5.3M
Q3 25
$-5.7M
$-562.0K
Q2 25
$-8.4M
$-3.4M
Q1 25
$-9.7M
Q4 24
$-8.4M
$-776.0K
Q3 24
$-8.7M
$-940.0K
Q2 24
$-9.5M
$-2.0M
Q1 24
$-12.7M
FCF Margin
HYPR
HYPR
MGLD
MGLD
Q4 25
-99.6%
Q3 25
-166.2%
-8.1%
Q2 25
-312.7%
-46.8%
Q1 25
-454.9%
Q4 24
-360.4%
-9.7%
Q3 24
-238.2%
-11.9%
Q2 24
-260.4%
-23.8%
Q1 24
-384.1%
Capex Intensity
HYPR
HYPR
MGLD
MGLD
Q4 25
1.2%
0.0%
Q3 25
3.8%
0.4%
Q2 25
19.3%
0.7%
Q1 25
22.1%
0.0%
Q4 24
0.3%
0.1%
Q3 24
4.4%
0.6%
Q2 24
2.0%
0.7%
Q1 24
4.4%
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HYPR
HYPR

Products$4.9M92%
Other$436.0K8%

MGLD
MGLD

Fund Management Related Party$4.6M60%
Food Products$1.7M22%
Beauty Products$1.2M15%
Other$268.0K4%

Related Comparisons